SOLICITATION NOTICE
66 -- Rapid Epitope Discovery System
- Notice Date
- 8/31/2011
- Notice Type
- Presolicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Office of Administration, 6011 Executive Blvd, 5th Floor, Rockville, Maryland, 20852-3804, United States
- ZIP Code
- 20852-3804
- Solicitation Number
- NIH-OLAO-OA5-NOI-2235959
- Archive Date
- 9/21/2011
- Point of Contact
- Van V. Holley, Phone: 301-594-9439
- E-Mail Address
-
holleyv@od.nih.gov
(holleyv@od.nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- The National Institutes of Health, Office of Acquisitions Station Support Simplified Acquisitions Branch on behalf of the National Eye Institute (NEI) intends to negotiate, on a non-competitive basis, with ProImmune, Inc 1901 60 th PL E STE L 2378, Bradenton, FL 34203. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority of FAR 13.106-1 (b)(1) and FAR 13.501 (a)(1) to use Simplified Acquisition Procedure for commercial items. The purpose of this notice is to obtain information regarding availability and capability from qualified small business organizations to provide the services stated herein. All small business organizations ( SB, SDB, WOSB, HUBZone, VOSB, and SDVOSB) are encouraged to respond to this notice. The North American Industry Classification System Code for this acquisition is 541711 and the size standard is 500 employees. The National Eye Institute requires the service from the contractor for the discovery of epitopes restricted to specific molecules of human HLA class II genes and to check HLA: peptide stability. The information will be used in designing diagnostic markers for uveitis in patients. ProImmunce is the only vendor that offers this service for specific HLA class II molecules because of its association with Uveitis disease. This information is critical for the progress of our "Bench to Bedside" project. Although similar metholody is performed in other laboratories in various academic institutions, it is not provided as a service and is not available for the specific HLA class II genes that are associated with uveitis disease. ProImmune's service has been widely accepted as a high quality service and is successfully used for epitope discovery in several human diseases. The information generated by their services is instrumental in developing vaccines for some viral diseases. No solicitation package will be issued. This notice of intent is not a request for competitive quotations; however, the Government will consider responses submitted to holleyv@od.nih.gov on or before 10:00 AM EST, Tueday, September 6, 20111. All information furnished must be in writing and must contain sufficient detail. A determination by the Government not to compete the proposed acquisition based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Please reference the announcement number NOI-2235959 on all correspondence submitted by email.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/OoA/NIH-OLAO-OA5-NOI-2235959/listing.html)
- Place of Performance
- Address: Bethesda Main Campus, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN02558149-W 20110902/110901000749-a93404ea882edc14774e1da6d1fcc06b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |